Gerber P, Nkrumah F K, Pritchett R, Kieff E
Int J Cancer. 1976 Jan 15;17(1):71-81. doi: 10.1002/ijc.2910170111.
A high incidence of oropharyngeal excretion of Epstein-Barr virus (EBV) has been observed in African children with Burkitt's lymphoma (BL) (48%) and matched controls (45%). This compares with an incidence of 77% in American patients with infectious mononucleosis (IM) and 13% in age-matched controls. Cross-neutralization tests between EBV strains derived from BL and IM patients and their sera failed to detect differences in the major neutralizing antigenic components. Cord-blood lymphocytes transformed by American EBV expressed only early viral functions (EBV nuclear and soluble complement-fixing antigens) and produced no detectable transforming activity. By contrast, cord-blood lymphocytes transformed by African EBV strains contained 0.2-0.3% of cells with EBV capsid and early antigen and produced EBV with transforming activity. These cells contained twice as many copies of EBV homologous DNA as the cells transformed by American EBV strains.
在患有伯基特淋巴瘤(BL)的非洲儿童(48%)及其匹配的对照组(45%)中,观察到口咽中爱泼斯坦-巴尔病毒(EBV)的高排泄率。相比之下,美国传染性单核细胞增多症(IM)患者中的发生率为77%,年龄匹配的对照组为13%。对源自BL和IM患者的EBV毒株及其血清进行的交叉中和试验未能检测到主要中和抗原成分的差异。由美国EBV转化的脐血淋巴细胞仅表达早期病毒功能(EBV核抗原和可溶性补体结合抗原),未产生可检测到的转化活性。相比之下,由非洲EBV毒株转化的脐血淋巴细胞含有0.2 - 0.3%带有EBV衣壳和早期抗原的细胞,并产生具有转化活性的EBV。这些细胞所含的EBV同源DNA拷贝数是由美国EBV毒株转化的细胞的两倍。